Safia Chatur, MD

Outpatient worsening HF as an endpoint in clinical trials? Thrilled to present our cross trial analysis in
HFp/mrEF @CVCTForum #LBCT session showing oral diuretic intensification
🎯 Occurs frequently
🎯 Is prognostically relevant
🎯 ⬇️ by all therapeutic classes
🎯 Has implications for trial efficiency

AI in #echocardiography is moving beyond automation.

At #ESCCongress2026, I discussed the evolution of #AIEcho in cardiomyopathy:

loops → phenotypes → scalable screening

Next frontier: moving from model #performance to clinical #implementation and impact.#CardiovascularAI

Join @eisselbacher et al for what is sure to be a fantastic session on the latest insights on aortic treatment👇🏼 @mghecho

@mvaduganathan elegantly making the case for combination "GDMT" in HFpEF #AHA25 @JACCJournals @ACCinTouch

Happening now!! Expert insights on HFpEF and CKM👇🏼 @hvanspall @mvaduganathan @lamcardio